Apotex Articles
Cangene's HepaGam gets US approval
6 February 2006
Cangene's HepaGam gets US approval
6 February 2006
Opportunity for Apotex to launch generic form of S-A's Plavix
30 January 2006
US court upholds Pfizer's Norvasc patent
30 January 2006
Apotex gets final OK for zonisamide capsules
9 January 2006
Trial date for US Plavix litigation
19 September 2005
Teva loses exclusivity on pravastatin, US FDA
18 July 2005
Problems for Sanofi on Lovenox ruling
27 June 2005
US decision on Sanofi Plavix patent nearer
6 June 2005
Plavix patent trial rescheduled again
16 May 2005
Sanofi says US Plavix trial is rescheduled
4 April 2005
Stock Commentary - New York
4 April 2005
Sanofi-Aventis/B-MS win Plavix patent battle in Canada
28 March 2005
Canada "must repeal Rx price controls:" study
7 March 2005
Update on Sanofi-Aventis' Plavix patent litigation
28 February 2005
European Plavix patent challenge for Sanofi-Aventis
31 January 2005
Alpharma files to remove stay on gabapentin launch
20 September 2004
Sanofi's Plavix ruling delayed in the USA
26 July 2004
Abbott wins Depakote patent sut against TorPharm
22 March 2004
Allergan wins Acular patent case
5 January 2004
GSK's Paxil losing ground fast, says IMS
6 October 2003
Stock Commentary - Europe
15 September 2003
Generic Paxil launch hits GSK's shares
15 September 2003
Phoenix boosts stake in Tamro to nearly 60%
8 September 2003
Sanofi-Synthelabo ups forecast on strong 1st-half, but fears persist over key patent
8 September 2003
GSK's Wellbutrin XL on track for approval
7 July 2003
Orchid in Apotex deal
9 June 2003
GSK wins protection for Ceftin antibiotic
12 May 2003
US federal court upholds GSK's Ceftin patent
12 May 2003
GSK settles Paxil lawsuit with Par Pharma
28 April 2003
Canadian generic price scam claimed in court
10 March 2003
UK court blocks Seroxat generics
24 February 2003
Key Paxil ruling comes early for GSK
20 January 2003
Stock Commentary - Europe
13 January 2003
Stock Commentary - Europe - 2 weeks to Dec 30
6 January 2003
Partial victory for GlaxoSmithKline in Paxil patent dispute
6 January 2003
Plavix defense extends to include Dr Reddy's
10 June 2002
Brazilian generic drug market developments
3 June 2002
Sanofi-Synthelabo to defend US clopidogrel patents
8 April 2002
Sanofi-Synthelabo files against Apotex
1 April 2002
Generic threats to Sanofi-Synthelabo's major antithrombotic Plavix?
18 February 2002
Stock Commentary - Europe
18 February 2002
In new job, Canadian Minister backs patents
28 January 2002
Canada Health backs down on buying Cipro from generics firms
24 October 2001
FDA's tentative OK for generic Depakote
8 June 2001
As ICH completes the CTD, what are the implications for generics?
28 February 2001
Controversial Canadian patent policy upheld
9 January 2001
FTC probe SB over Paxil suit
7 December 2000
Avandia CPMP knockback overshadows SB's promising growth
25 October 1999
Apotex embroiled in row over deferiprone
21 October 1999
First ticlopidine generic approved in USA
8 July 1999
Apotex acquires Ibfarma stake
29 March 1999
Paxil CR approval in USA; purely a defensive product for SB?
23 February 1999
Apotex renews support for Cangene's R&D program
16 February 1999
Lilly paying $4 million to settle Prozac case
27 January 1999
Doctor attacks deferiprone ruling
30 December 1998
New Study Questions Role Of Deferiprone
13 August 1998
Chiesi Aims For Top 20 Place In Italian Market
5 August 1998
Canadian High Court Slams Drug Laws
21 July 1998
Stock Commentary Europe
28 May 1998
SB Files Lawsuit In USA Over Paxil
26 May 1998
Abbott Loses Apotex Battle
30 April 1998
Canada's Generics Firms Outraged At Patent Moves
17 March 1998
Canadian Pharma Patent Infringement Regs In Court
18 February 1998
Apotex Victorious In Fluconazole Battle
16 February 1998
Canada Drug Patent Regs Eased Slightly
28 January 1998
Apotex Sets Up Italian Generics Company
4 December 1997
Apotex Opens Office In China
16 October 1997
Novopharm Fined $1.25m For Contempt Of Court
9 October 1997
Draxis Health Lines Up With Mylan For Drug Marketing
7 October 1997
Apotex Launches Generic Zantac In USA
25 September 1997
Apotex Enters French Generics Market
18 June 1997
Generic Prozac
5 May 1997
Canadian Generics Maker's Warning
7 April 1997
Court Battle Over For Apotex And Merck
4 April 1997
Acquisitions And Mergers Continue, Led By Novartis
6 January 1997
Apotex Opens TorPharm
9 December 1996
Assessing The Worldwide Market For Generics
28 October 1996
ACIC Sells Manufacturing Division To Apotex
14 October 1996
C$4 Million Profits For Cangene
7 October 1996
Novopharm Wins Generic Prozac Battle
7 October 1996
Apotex Acquires Fine Chemicals Firm
12 August 1996
Apotex Buys In Mexico
29 July 1996
New Italo/US Group Seeks UK, Other Alliances
1 July 1996
Koor And Apotex In Joint Venture
8 April 1996
Lilly Gets Interim Injunction on Prozac
1 April 1996
Canadian Bid To Stop New Generics Firm
1 April 1996
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
